Bruce Keyt - Mar 13, 2024 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Misbah Tahir, by power of attorney
Stock symbol
IGMS
Transactions as of
Mar 13, 2024
Transactions value $
-$39,502
Form type
4
Date filed
3/15/2024, 07:49 PM
Previous filing
Mar 14, 2024
Next filing
Mar 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Sale -$20.7K -2.1K -1.2% $9.88 174K Mar 13, 2024 Direct F1, F2
transaction IGMS Common Stock Sale -$18.8K -1.84K -1.06% $10.17 172K Mar 14, 2024 Direct F1, F3
holding IGMS Common Stock 4.04K Mar 13, 2024 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 This transaction was executed in multiple trades at prices ranging from $9.625 to $10.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $9.80 to $10.43. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 The securities are held directly by the reporting person's spouse.